Blog - INTERNET MÉDICA

Antidiabéticos Orais na Insuficiência Cardíaca: Artigos de Revisão (Antidiabetic Agents on Heart Failure: Reviews)

Por Paulo Leite 16/03/2023

■ Tópicos emergentes em insuficiência cardíaca: inibidores do cotransportador sódio-glicose 2 (iSGLT2) na IC

E A Bocchi, A B Biolol, L Z Moura et al

Arq Bras Cardiol 2021, vol 116 (2)

https://www.scielo.br/j/abc/a/tFQHn8rLHS5Fw5JHKPymjPf/?lang=pt (portugese)

https://www.scielo.br/j/abc/a/tFQHn8rLHS5Fw5JHKPymjPf/?lang=en (english)

■ The effects of antidiabetic agentes on heart failure

M Wijnen, E J J Duschek, H Boom, M van Vliet

Neth Heart J 2022, vol 30 (2): 65-75

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799792/

■ Gliflozins for the treatment of congestive heart failure and renal failure in type 2 diabetes

A K Seoudy, D M Schulte, T Hollstein et al

Dtsch Arztebl Int 2021, vol 118 (8): 122-129

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204375/

■ Glicozinas: mais do que antidiabétis orais. Uma breve revisão da literatura

V Gonzalez

Rev Uruq. Cardiol 2021, vol 36 (2): e401

http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-04202021000201401&lng=es&nrm=iso&tlng=es

■ The role of SGLT2 inhibitors in heart failure: a systematic review and meta-analysis: a systematic review and meta-analysis

V Tsampasian, R Baral, R Chattopadhyay et al

Cardiol Res Pract 2021, 2021: 9927533

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397556/

■ SGLT2 inhibitors in type 2 diabetes mellitus and heart failure – a concise review

Daria M. Keller, Natasha Ahmed, Hamza Tariq et al

J Clin Med. 2022 Mar; 11(6): 1470

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952302/

■ Acesso gratuito

■ Um dos Blog de Medicina mais acessado em todo o mundo. Mais de 900 temas médicos já disponíveis online

■ Use o mecanismo de busca – PESQUISAR na home page.

■ Acesse ARQUIVO e encontre os temas incluídos no Blog a cada mês, desde maio 2017

■ Blog Internet Médica – www.internetmedica.com.br

■ Médico Responsável: Dr Paulo Fernando Leite

CRMMG: 7026

Belo Horizonte/MG/Brasil

Email: pfleite1873@gmail.com

Março 2023

Inteligência Artificial em Medicina Cardiovascular (Artificial Intelligence in Cardiovascular Medicine: Texas Heart Institute)

Por Paulo Leite 16/03/2023

■ Artificial intelligence in echocardiography

S A Coulter, K Campos

Texas Heart Inst J 2022, vol 49 (2): e217671

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053659/

■ Artificial intelligence in Cardiovascular Medicine: Historical overview, current status, and future directions

Zvonimir Krajcer

Texas Heart Inst J 2022, vol 49 (2): e207527

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053657/

■ Artificial intelligence for education, proctoring, and credentialing in Cardiovascular Medicine

Z Krajcer

Texas Heart Inst J 2022, vol 49 (2): e217572

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053661/

■ Artificial intelligence and machine learning in cardiac electrophysiology

M M John, A Banta, A Post et al

Texas Heart Inst J 2022, vol 49 (2): e217576

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808396/

■ Telerobotic endovascular interventions and their potential for cerebrovascular treatment

M Berczeli, G W Britz, T Loh, A B Lumsden

Texas Heart Inst J 2022, vol 49 (2): e217608

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053666/